Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study
Titel:
Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study
Auteur:
Anstee, Q.M. Harrison, S. Sanyal, Arun J. Ratziu, V. Rinella, M. Younossi, Z.Y. Boursier, J. Francque, S. Geerts, A. Petta, S. Bugianesi, E- Romero-Gomez, M. Schattenberg, J.M. Sarkar, S. Bonacini, M. Yataco, M. Porayko, M. Siddique, A. Dufour, J. Ferro, T. A.Venugopal, Zaru, L. Shringarpure, R. MacConell, L. Goodman, Z. Loomba, R.